embarked on a multi-year journey of IT transformation to enhance our time-to-market and simplify internal operational processes, as well as implemented an autonomous network to improve both CAPEX and OPEX
sustainability journey $ Footprinting & Lifecycle Analysis to quantify climate impact Strategic Advisory to guide decision-making, targets, and goal-setting Renewable Energy Sourcing and planning Project
asset quality management for its loan portfolio and focus on expanding into profitable segment with better asset quality taking into careful considerations the economic conditions. As such, the overall
and profitable i.e. expanding the business to cover the production of human and animal medicines, expanding in varieties of product, increasing revenue, reducing costs and expenses, etc. The Company
cycle. On the journey to achieve this, IVL is committed to: Cost transformation via the Olympus program, leading to $350M run-rate savings by 2023 Asset full potential with strong revenue and margin
Dusit Thani PLC Management Discussion and Analysis For 4Q19 and FY2019 P a g e | 1 Executive Summary 2019 marked our first year in the second phase of the Company’s 9-year strategic journey (2019
Dusit Thani PLC Management Discussion and Analysis For 4Q19 and FY2019 P a g e | 1 Executive Summary 2019 marked our first year in the second phase of the Company’s 9-year strategic journey (2019
Dusit Thani PLC Management Discussion and Analysis For 4Q19 and FY2019 P a g e | 1 Executive Summary 2019 marked our first year in the second phase of the Company’s 9-year strategic journey (2019
focused on its financial objective to double EBITDA by 2023 in a disciplined manner by utilizing its current balance sheet and future operating cash flows. On the journey to achieve this, IVL is committed
decile total shareholder returns (TSR) position vs. peers and a strong cash flow through the cycle. As presented at our Capital Markets days in Feb 2020, On the journey to achieve above objectives, IVL is